Clinical Trials Sponsored by Medotech A/S

Total 2510 results

University of Birmingham
Novo Nordisk A/S; Wellcome Trust

Completed

Liraglutide Efficacy and Action in Non-Alcoholic Steatohepatitis (LEAN)

Nonalcoholic Steatohepatitis

United Kingdom
Otsuka Pharmaceutical Development & Commercialization...
H. Lundbeck A/S

Completed

Phase 1 Study to Assess the Safety/Tolerability of Brexpiprazole as Adjunctive Therapy in Elderly Subjects With Major Depressive Disorder

Major Depressive Disorder

United States
University of Copenhagen
PenSam, Denmark; Mobile Fitness A/S

Completed

SoSu-liv. Mobile Media for Health Promotion

Obesity
Hospital Geral de Fortaleza
Medley S∕A Indústria Farmacêutica

Completed

Improvement of Quality of Life in Patients Using Low-dose Pills in the Different Phases of Menacme

Quality of Life | Menopause | Contraception

Brazil
Karolinska Institutet
Novo Nordisk A/S; GlaxoSmithKline; Göteborg University

Completed

A Placebo-Controlled Study to Investigate the Onset of Action of Paroxetine in Premenstrual Dysphoria

Premenstrual Dysphoric Disorder | Premenstrual Syndrome

Sweden
Jikei University School of Medicine
Novo Nordisk A/S

Unknown

Jikei Optimal Insulin Therapy in Type 2 Diabetes

Diabetes Mellitus, Type 2

Japan
Washington University School of Medicine
Novo Nordisk A/S

Not yet recruiting

Primary Prevention and Uterine Preservation in Premenopausal Women With Obesity and Endometrial Hyperplasia

Endometrial Hyperplasia

United States
Forma Therapeutics, Inc.
Medpace, Inc.

Completed

A SAD/MAD to Assess the Safety, PK/PD of FT-4202 in Healthy Volunteers and Sickle Cell Disease Patients

Healthy Volunteers | Sickle Cell Disease

United States
Otsuka Pharmaceutical Development & Commercialization...
H. Lundbeck A/S

Completed

Trial to Evaluate the Short-term Safety & Efficacy of Brexpiprazole Monotherapy in the Treatment of Adolescents With Schizophrenia

Schizophrenia

United States
Otsuka Pharmaceutical Development & Commercialization...
H. Lundbeck A/S

Completed

Brexpiprazole in Treatment of Children and Adolescents With Irritability Associated With Autism Spectrum Disorder (Anchor)

Irritability Associated With Autism Spectrum Disorder (ASD)

United States
Nordisk Rebalance A/S
Linkoeping University; University Hospital, Linkoeping

Completed

Effect of Postbiotic Product on Colonic Barriers in IBS

IBS - Irritable Bowel Syndrome

Sweden
Otsuka Pharmaceutical Development & Commercialization...
H. Lundbeck A/S

Completed

A Study of Flexible Dose Brexpiprazole as Monotherapy or Combination Therapy in the Treatment of Adults With Post-traumatic Stress Disorder (PTSD)

Stress Disorders, Post-Traumatic

United States
WellSpan Health
Ambu A/S; York Opioid Collaborative, Pennsylvania

Terminated

The Analgesic Efficacy of Continuous Sub-fascial Bupivacaine Infusion and Lidocaine Patches in Post-cesarean Patients With Opiate Use Disorder: A Comparative Efficacy Analysis

Pregnancy Related | Cesarean Section | Medication Assisted Treatment | Opioid Dependence | Opioid Use | Opioid Abuse | Opioid-use Disorder | Infusion Catheter, Wound | Lidopatch | Ambu ACTion

United States
Mountain Diabetes and Endocrine Center
Novo Nordisk A/S

Completed

Basal Insulin Glycemic ControL With DEglugec vs Aspart Via Pump (BIG LEAP)

Type1 Diabetes Mellitus

United States
Otsuka Pharmaceutical Development & Commercialization...
H. Lundbeck A/S

Completed

Safety and Tolerability Study of Flexible Dosing of Brexpiprazole in the Treatment of Subjects With Agitation Associated With Dementia of the Alzheimer's Type

Nervous System Diseases | Alzheimer's Disease | Mental Disorder | Agitation Associated With | Alzheimer's Type

France, United States, Bulgaria, Slovenia, United Kingdom, Russian Federation, Ukraine, Finland, Canada
Rigshospitalet, Denmark
Novo Nordisk A/S; Danish Nurses Organisation

Completed

Needs Assessment Tool Integrated in Clinical Practice of Head and Neck Cancer Rehabilitation (NEAT)

Head and Neck Neoplasms

Denmark
Phoenix VA Health Care System
Novo Nordisk A/S

Unknown

The Effect of Liraglutide on Dietary Lipid Induced Insulin Resistance in Humans

Insulin Resistance

United States
Meabco A/S
Meddoc; Norwegian University of Life Sciences

Completed

BP-C1 in Short-term Treatment of Patients With Metastatic Breast Cancer

Metastatic Breast Cancer | Stage IV Breast Cancer

Thailand, Russian Federation
Meabco A/S
Meddoc; Norwegian University of Life Sciences

Completed

BP-C1 Monotherapy in Patients With Metastatic Breast Cancer Cancer: Estimation of Optimal Duration of Treatment

Metastatic Breast Cancer | Stage IV Breast Cancer

Thailand, Russian Federation
Glycom, Inc.
University of North Carolina

Completed

Effect of HMOs as Nutritional Support for Normal Bowel Movements in IBS Patients (GRIPS)

Irritable Bowel Syndrome (IBS)

United States
Professor Mikkel Østergaard
Novartis Healthcare A/S

Unknown

Treat-to-target With Secukinumab in Axial Spondyloarthritis (TRACE)

Ankylosing Spondylitis | Axial Spondyloarthritis

Denmark
Meabco A/S
Meddoc; Norwegian University of Life Sciences

Completed

BP-C1 in Short-term Treatment of Metastatic Pancreatic Cancer

Metastatic Pancreatic Cancer | Unresectable Pancreatic Cancer

Egypt
Otsuka Pharmaceutical Development & Commercialization...
H. Lundbeck A/S

Completed

Open-label Study to Evaluate the Effectiveness of an Intramuscular Formulation of Aripiprazole (OPC-14597) as Maintenance Treatment in Patients With Bipolar I Disorder (ATLAS)

Bipolar I

United States, France, Romania, Poland, Canada, Hungary, Japan, Korea, Republic of, Malaysia, Taiwan
Otsuka Pharmaceutical Development & Commercialization...
H. Lundbeck A/S

Completed

Efficacy, Safety, and Tolerability of an Intramuscular Formulation of Aripiprazole (OPC-14597) as Maintenance Treatment in Bipolar I Patients

Bipolar I Disorder

United States, Taiwan, Romania, Korea, Republic of, Japan, Poland, Canada
Otsuka Pharmaceutical Development & Commercialization...
H. Lundbeck A/S

Completed

Study of the Safety and Efficacy of Fixed-dose Brexpiprazole (OPC-34712) as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder With and Without Anxious Distress

Mental Disorders | Depressive Disorder | Depression | Mood Disorders | Depressive Disorder, Major

United States, Germany, Poland, Hungary, Slovakia
Otsuka Pharmaceutical Development & Commercialization...
H. Lundbeck A/S

Completed

Trial to Assess the Pharmacokinetics, Safety, Tolerability of Oral Brexpiprazole in Children (6 to <13 Years Old) With Central Nervous System Disorders

ADHD | Conduct Disorder | Oppositional Defiant Disorder | Autism | Bipolar I Disorder

United States
Otsuka Pharmaceutical Development & Commercialization...
H. Lundbeck A/S

Completed

Study to Determine the Pharmacokinetics, Safety & Tolerability of Aripiprazole in Adults With Schizophrenia

Schizophrenia

United States
Kathleen Dungan
Novo Nordisk A/S

Completed

Prandial Insulin Dosing in Hospitalized Patients (ICHO)

Diabetes | Admitting Hospital | Non-critically Ill

United States
Otsuka Pharmaceutical Development & Commercialization...
H. Lundbeck A/S

Terminated

Safety and Tolerability Study of Single-dose Administration of Brexpiprazole in Adult Subjects With Schizophrenia

Schizophrenia

United States
Michigan Institution of Women's Health PC
Coloplast A/S

Completed

Prospective Performance Analysis of the Exair(TM) Prolapse Repair System in the Treatment of Pelvic Organ Prolapse

Pelvic Organ Prolapse
Arne Astrup
Biocare Copenhagen A/S

Completed

Encapsulated Nutrients' Acute Effects on Appetite; ENcapsulated, lipiD, aminO, pRobiotic, SatiEty (ENDORSE)

Appetite; Lack or Loss, Nonorganic Origin

Denmark
Otsuka Pharmaceutical Development & Commercialization...
H. Lundbeck A/S

Completed

Study to Assess the Safety, Tolerability and Pharmacokinetics of Oral Brexpiprazole (OPC- 34712) in Adolescents With Schizophrenia

Schizophrenia

United States
Centre Hospitalier Universitaire de Besancon
H. Lundbeck A/S

Completed

Study of Transcranial Direct Current Stimulation (tDCS) as add-on Treatment for Resistant Major Depression (DEPRESCO)

Resistant Major Depression

France
Otsuka Pharmaceutical Development & Commercialization...
H. Lundbeck A/S

Completed

Safety and Tolerability Study of Aripiprazole IM Depot in Adult Subjects With Schizophrenia

Nervous System Diseases | Schizophrenia | Mental Disorder

United States
Max-Planck-Institute of Psychiatry
Novo Nordisk A/S

Terminated

Neuropsychological Effects of Hydrocortisone in Patients With Partial Adrenal Insufficiency (CSMünchen01)

Partial Corticotrope Insufficiency

Germany
Jeppe Skov
Novo Nordisk A/S

Completed

GLP-1: Acute Effects on Kidney Function in Healthy Men

Kidney Functional

Denmark
Ludwig-Maximilians - University of Munich
H. Lundbeck A/S

Completed

Beta-CIT-SPECT and Neurophysiology in Depression

Depression

Germany
University Health Network, Toronto
GlaxoSmithKline; H. Lundbeck A/S

Completed

Memory Functioning and Antidepressant Treatment

Depression | Major Depressive Disorder

Canada
Hospital of South West Jutland
Novo Nordisk A/S

Recruiting

Recovering From Bariatric Surgery: the Effects of Early Initiated and Supervised Mobilization

Physical Activity | Postoperative Pain, Acute | Postoperative Pain, Chronic | Bariatric Surgery | Mobilization

Denmark
Forma Therapeutics, Inc.
Emory University

Not yet recruiting

Study of the Effect of Etavopivat on Cerebral Hemodynamic Response in Children With Sickle Cell Disease

Sickle Cell Disease

United States
Finn Gustafsson
Novo Nordisk A/S; Abbott

Recruiting

Screening for Advanced Heart Failure IN Stable outPatientS - The SAINTS Study (SAINTS B) (SAINTS B)

Heart Failure With Reduced Ejection Fraction | Advanced Heart Failure

Denmark
Otsuka Pharmaceutical Development & Commercialization...
H. Lundbeck A/S

Completed

Brexpiprazole in Treatment of Children and Adolescents With Irritability Associated With Autism Spectrum Disorder for Subjects That Have Completed Participation in 331-201-00148

Irritability Associated With Autism Spectrum Disorder

United States
Otsuka Pharmaceutical Development & Commercialization...
H. Lundbeck A/S

Active, not recruiting

Safety and Tolerability of Open-Label Flexible-dose Brexpiprazole as Maintenance Treatment in Adolescents With Schizophrenia

Schizophrenia

United States
Otsuka Pharmaceutical Development & Commercialization...
H. Lundbeck A/S

Completed

A 12-week Extension Trial to Evaluate the Safety and Tolerability of Brexpiprazole in the Treatment of Subjects With Agitation Associated With Dementia of the Alzheimer's Type

Alzheimer's Disease

United States
Otsuka Pharmaceutical Development & Commercialization...
H. Lundbeck A/S

Completed

A Trial to Evaluate the Safety, Efficacy, and Tolerability of Brexpiprazole in Treating Agitation Associated With Dementia of the Alzheimer's Type

Alzheimer Dementia | Agitation Associated With Alzheimer's Dementia

United States
Otsuka Pharmaceutical Development & Commercialization...
H. Lundbeck A/S

Withdrawn

Open-label Brexpiprazole fMRI Trial in Adults With Major Depressive Disorder and Anxiety

Major Depressive Disorder (MDD)
University of Copenhagen
Novo Nordisk A/S; Elsass Foundation

Active, not recruiting

Physical Activity, Sports and Health in Adults With Intellectual Disabilities

Intellectual Disability

Denmark
Manchester University NHS Foundation Trust
Novo Nordisk A/S

Completed

Comparison of Day and Night Closed-loop With Faster-acting Insulin Aspart With Insulin Aspart (AP-MFT-01)

Diabetes Mellitus, Type 1

United Kingdom
Lecube, Albert, M.D.
Novo Nordisk A/S; Dynamic Solutions

Completed

Study to Assess the Efficacy of Liraglutide in Patients With Type 2 Diabetes Mellitus

Type 2 Diabetes

Spain
Otsuka Pharmaceutical Development & Commercialization...
H. Lundbeck A/S

Completed

A Phase 3, 12-week, Multicenter, Randomized, Double-blind, Placebo-controlled Trial to Evaluate the Efficacy, Safety, and Tolerability of 2 Fixed Doses of Brexpiprazole in the Treatment of Alzheimer's Agitation

Nervous System Diseases | Alzheimer's Disease | Mental Disorder | Agitation Associated With | Alzheimer's Type

Spain, United States, Germany, Croatia, Serbia, Russian Federation, Ukraine

Clinical Trials Sponsored by Medotech A/S

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Austria

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations